Revolutionising companion animal cancer therapeutic innovations

0 in 4
Dogs will develop cancer at some point during their lifetime
0%
Of dogs aged 10 or older may develop cancer
0%
Of deaths in dogs are reported to be caused by cancer
0%
Of malignant bone tumours in dogs are osteosarcoma

Our mission

To develop cancer drugs in pet patients,
for pet patients.

What we do

ValiRx Animal Health develops innovative veterinary oncology therapeutics for companion animals. We apply advanced biological science and translational research to deliver scientifically validated, accessible pet cancer care solutions for veterinary medicine, thereby supporting companion animal health.

Our foundation

Built on ValiRx plc’s life sciences heritage, we combine scientific, technological and commercial expertise to bridge discovery and deliver clinical impact. Using translational models, we accelerate clinical relevant therapy development while reducing risk and improving outcomes.

Our approach

Working through strategic partnerships and licensing collaborations, we are building a robust veterinary oncology pipeline designed to deliver better outcomes for companion animals and create value for partners across the veterinary health sector.

Our vision is to revolutionise companion animal cancer care through ethical accessible solutions

A dog standing up

See how it all works

Partner with us

Asset partners

Accelerate your in-licensing, academic innovation and commercialisation opportunities.

Veterinary collaborators

Join our network as a trial site, contribute samples, or collaborate on comparative oncology research.

Pet parent community

Help raise awareness, advocate for better treatment options, and connect pets with clinical trials.

Get in touch to learn more

Get in touch